Asset

Carbinoxamine maleate

Aytu BioPharma Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 022556NDAAYTU BIOSCIENCE INC

Marketed products (1)

  • KARBINAL ER